Related Experiment Video
Updated: Jun 21, 2026

Dynamic Continuous Blood Extraction from Rat Heart via Noninvasive Microdialysis Technique
Published on: September 13, 2022
Microdialysis: a technique for pharmacokinetic-pharmacodynamic studies of oncological drugs
1Department of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, P.R. China.
Abstract:
Solid tumors have several barriers that may limit drug penetration and provide inherent mechanisms of resistance. Therefore, the evaluation of antineoplastic agents should base on tumor drug exposure and antitumor activity. Owing to selective access to the extracellular space of the tumor, which acts as target site for most antineoplastic drugs, monitoring drug disposition and corresponding antitumor activity, microdialysis (MD), a probe-based sampling technique, satisfies regulatory requirements for pharmacokinetic- pharmacodynamic (PK-PD) studies. MD is a powerful tool for PK-PD studies of oncological drugs, which would allow better understanding of exposure-response relationships and contributes to the research and development of oncological drugs. Recent progresses in the development of MD for estimating PK-PD studies of oncological drugs are summarized in this review. Special preclinical application examples of MD for PK-PD studies of oncological drugs organized by types of antineoplastic drugs and informations collected are also described. In conclusion, the role of MD in preclinical PK-PD studies of oncological drugs has been confirmed and it has provided a strong foundation for further clinical research.
Insights
Microdialysis (MD) effectively monitors drug disposition and antitumor activity in solid tumors. This technique enhances understanding of pharmacokinetic-pharmacodynamic (PK-PD) relationships for oncological drug development.
Area of Science:
- Oncology
- Pharmacology
- Biomedical Engineering
Background:
- Solid tumors present drug penetration barriers and resistance mechanisms.
- Evaluating antineoplastic agents requires correlating tumor drug exposure with antitumor activity.
Purpose of the Study:
- To review recent advancements in microdialysis (MD) for preclinical pharmacokinetic-pharmacodynamic (PK-PD) studies of oncological drugs.
- To highlight the role of MD in understanding drug disposition and antitumor responses in solid tumors.
Main Methods:
- Microdialysis (MD), a probe-based sampling technique, accesses the tumor's extracellular space.
- MD enables monitoring of drug disposition and corresponding antitumor activity for PK-PD analysis.
Main Results:
- MD is a validated tool for preclinical PK-PD studies in oncology.
- The review summarizes MD applications across various antineoplastic drug types.
- MD facilitates a better understanding of exposure-response relationships for cancer drugs.
Conclusions:
- Microdialysis (MD) plays a confirmed role in preclinical PK-PD studies of oncological drugs.
- MD provides a robust foundation for future clinical research in cancer drug development.
More Related Videos
08:21Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
08:17In Vivo Microdialysis Method to Collect Large Extracellular Proteins from Brain Interstitial Fluid with High-molecular Weight Cut-off Probes
Published on: September 26, 2018
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Therapeutic Drug Monitoring: Drug Analysis Methods
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacodynamic Models: Overview
Therapeutic Drug Monitoring: Overview and Classification